Medical device recalls
38845 federal recalls on file. Federal recalls for medical devices — surgical equipment, monitors, diagnostic tools, implants, home health devices. Sourced from the FDA.
- 2026-02-11FDA-DeviceVANTIVE US HEALTHCARE LLCClass IIStop using affected Vantive Prismaflex TPE2000 sets
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVANTIVE US HEALTHCARE LLCClass IIStop using affected Prismaflex HF1000 dialyzer sets
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVANTIVE US HEALTHCARE LLCClass IIStop using affected Prismaflex HF1000 dialyzer sets
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVANTIVE US HEALTHCARE LLCClass IICheck your Prismaflex M150 dialyzer sets immediately
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVANTIVE US HEALTHCARE LLCClass IIStop using Vantive Prismaflex M100 dialyzer sets
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVANTIVE US HEALTHCARE LLCClass IICheck your OXIRIS dialyzer set immediately
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVANTIVE US HEALTHCARE LLCClass IICheck your Vantive Prismaflex ST150 dialyzer set
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVANTIVE US HEALTHCARE LLCClass IIStop using affected Vantive Prismaflex ST100 sets
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus electrosurgical knife KD-645L
A deterioration of the cutting knife, including overheating and burning, can contribute to tip breakage during use.
- 2026-02-11FDA-DeviceOlympus Corporation of the AmericasClass IIStop using Olympus KD-640L electrosurgical knives
A deterioration of the cutting knife, including overheating and burning, can contribute to tip breakage during use.
- 2026-02-11FDA-DeviceBeckman Coulter, Inc.Class IIStop using recalled Beckman Coulter diluent lots
Due to specific lots of diluents contributing to elevated platelet Daily Checks background counts cycle with use with analyzers.
- 2026-02-11FDA-DeviceBoston Scientific CorporationClass ICheck your AXIOS Stent lot number immediately
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston Scientific CorporationClass IContact your doctor about AXIOS Stent
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston Scientific CorporationClass ICheck HOT AXIOS Stent lot numbers immediately
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston Scientific CorporationClass IContact your doctor about Boston Scientific AXIOS Stent
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston Scientific CorporationClass IContact your doctor about AXIOS Stent recall
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston Scientific CorporationClass IStop using Boston Scientific AXIOS Stent
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-04FDA-DeviceMiach OrthopaedicsClass IICheck BEAR Implant Model 1000 expiration date
Incorrect expiration date on label that extends beyond the product's documented/approved shelf life. With an incorrect expiration date, the UDI will also be incorrect.
- 2026-02-04FDA-DeviceLSL Healthcare Inc.Class IIStop using LSL Healthcare Central Line Dressing Kit
BD ChloraPrep Triple Swabsticks, a component within the kits, exhibit an open seal on the packaging of the applicators.
- 2026-02-04FDA-DeviceLimFlow, Inc.Class IICheck LimFlow Vector device expiration date
Incorrect expiration date
- 2026-02-04FDA-DeviceCareFusion 303, Inc.Class IICheck your BD Alaris Pump Module 8100
Due to a number of modules flashed with a date and time associated with the daylight savings time (DST) adjustment that may cause connectivity issue with hospital networks. This issue only affects the Interoperability workflow for devices with a DST invalid timestamp, impacting connectivity of the PCU to the hospital network
- 2026-02-04FDA-DevicePhilips North AmericaClass IICheck Philips MR system software version
The potential for stiffness value errors when viewing exported MR Elastography (MRE) stiffness maps to viewer Picture Archiving and Communication System (PACS).
- 2026-02-04FDA-DevicePhilips North AmericaClass IICheck Philips dStream MRI elastography readings
The potential for stiffness value errors when viewing exported MR Elastography (MRE) stiffness maps to viewer Picture Archiving and Communication System (PACS).
- 2026-02-04FDA-DevicePhilips North AmericaClass IICheck your Philips MR 7700 MRI system software
The potential for stiffness value errors when viewing exported MR Elastography (MRE) stiffness maps to viewer Picture Archiving and Communication System (PACS).
- 2026-02-04FDA-DevicePhilips North AmericaClass IICheck Philips MR 7700 MRI stiffness readings
The potential for stiffness value errors when viewing exported MR Elastography (MRE) stiffness maps to viewer Picture Archiving and Communication System (PACS).
- 2026-02-04FDA-DevicePhilips North AmericaClass IIContact Philips if you operate Ingenia Elition X MRI
The potential for stiffness value errors when viewing exported MR Elastography (MRE) stiffness maps to viewer Picture Archiving and Communication System (PACS).
- 2026-02-04FDA-DevicePhilips North AmericaClass IICheck Philips Ingenia Elition S MRI software
The potential for stiffness value errors when viewing exported MR Elastography (MRE) stiffness maps to viewer Picture Archiving and Communication System (PACS).
- 2026-02-04FDA-DevicePhilips North AmericaClass IICheck Philips Ingenia Ambition X MRI software
The potential for stiffness value errors when viewing exported MR Elastography (MRE) stiffness maps to viewer Picture Archiving and Communication System (PACS).
- 2026-02-04FDA-DevicePhilips North AmericaClass IIContact Philips about your Ingenia Ambition S. system
The potential for stiffness value errors when viewing exported MR Elastography (MRE) stiffness maps to viewer Picture Archiving and Communication System (PACS).
- 2026-02-04FDA-DevicePhilips North AmericaClass IIContact Philips about your Ingenia 3.0T CX MRI system
The potential for stiffness value errors when viewing exported MR Elastography (MRE) stiffness maps to viewer Picture Archiving and Communication System (PACS).
Get notified about new device recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief